Blood-Brain Barrier Blocks 98% of Small Molecules and Nearly All Biologics from Reaching the Brain

The blood-brain barrier prevents most drugs from reaching brain cells. Treating neurological diseases requires invasive brain surgery for direct injection, which is risky and cannot treat the whole brain uniformly. Focused ultrasound with microbubbles is emerging but remains early-stage.

AAV9 transduces <5% of neurons after systemic IV delivery in adults. LNPs cannot cross the BBB without modification. Focused ultrasound (FUS) with microbubbles transiently opens the BBB — a 2026 Nature study showed low-pressure FUS induces transient tight junction reorganization while high-pressure causes persistent opening. The largest FUS trial enrolled 100 glioblastoma patients across EU and US (2025). Cordance Medical received FDA Breakthrough Device Designation for BBB-opening liquid biopsy. Engineered capsids like AAV.PHP.eB cross the BBB in C57BL/6 mice via LY6A receptor, but LY6A does not exist in primates.

Why It Matters

6.2M Americans have Alzheimer's, 30,000 have ALS, 30,000 have Huntington's. Plus hundreds of rare pediatric neurological disorders. Intracranial surgery costs $50K-150K per procedure. CNS drugs have ~85% Phase II/III failure rate — the highest of any therapeutic area.

Startup Approach

Develop engineered AAV capsids or non-viral nanoparticles that cross the human BBB efficiently after IV injection. Identify human BBB transcytosis receptors (transferrin receptor, LRP1). Or develop improved focused ultrasound protocols with better spatial control and repeatability.

NIH Funding

NINDS BRAIN Initiative funds delivery technologies. NIH SCGE program calls out CNS delivery as major gap. HEAL Initiative funds CNS-targeted approaches. ~$200M+ in active NIH grants for CNS gene therapy delivery.

Who's Working On It

Voyager/Neurocrine (TRACER capsid, transferrin receptor targeting), Capsida Biotherapeutics (engineered capsids), Passage Bio (intracisterna magna delivery), InSightec (MRI-guided FUS), Carthera (implantable ultrasound), Cordance Medical (FDA Breakthrough Device)